Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q2 FY22 results · Jul–Sep 2021
Abbott India reported revenue from operations of ₹1,222.06 crore (up 15.9% from Q2 FY21) and net profit of ₹192.33 crore (up 6.4% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,222.06 | 1,054.85 | +15.9% | 1,217.83 | +0.3% |
| Other income | 18.21 | 22.06 | −17.5% | 19.21 | −5.2% |
| Total income | 1,240.27 | 1,076.91 | +15.2% | 1,237.04 | +0.3% |
| Profit before tax | 257.19 | 243.69 | +5.5% | 263.59 | −2.4% |
| Net profit for the period | 192.33 | 180.73 | +6.4% | 195.76 | −1.8% |
| EPS, basic (₹) | 90.51 | 85.05 | +6.4% | 92.12 | −1.7% |
| Net margin (%) | 15.7 | 17.1 | 16.1 |
Standalone
- Filed with BSE
- 12 Nov 2021, 14:17 IST
- Board meeting
- 12 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE